Medicina
Departamento
Eli Lilly and Company
Indianapolis, EE. UU.Publicaciones en colaboración con investigadoras/es de Eli Lilly and Company (4)
2023
-
Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
Rheumatology and Therapy, Vol. 10, Núm. 5, pp. 1319-1333
2022
-
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study) (Rheumatology and Therapy, (2022), 9, 2, (589-608), 10.1007/s40744-021-00423-8)
Rheumatology and Therapy
-
Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study)
Rheumatology and Therapy, Vol. 9, Núm. 2, pp. 589-608
2002
-
Características de la versión española del cuestionario de calidad de vida QLSM-H en sujetos adultos con deficiencia de hormona de crecimiento tratados con somatotropina. Estudio piloto
Endocrinologia y Nutricion, Vol. 49, Núm. 4, pp. 105-112